| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.8 | $0-$5k | 0.00 |
Summary
A vulnerability described as critical has been identified in IBM WebShere MQ 9.1.0.0/9.1.0.1/9.1.1. The impacted element is an unknown function. The manipulation results in inadequate encryption. This vulnerability is cataloged as CVE-2018-1925. The attack may be launched remotely. There is no exploit available.
Details
A vulnerability was found in IBM WebShere MQ 9.1.0.0/9.1.0.1/9.1.1. It has been classified as critical. Affected is an unknown code block. The manipulation with an unknown input leads to a inadequate encryption vulnerability. CWE is classifying the issue as CWE-326. The product stores or transmits sensitive data using an encryption scheme that is theoretically sound, but is not strong enough for the level of protection required. This is going to have an impact on confidentiality, integrity, and availability. CVE summarizes:
IBM WebShere MQ 9.1.0.0, 9.1.0.1, 9.1.1 uses weaker than expected cryptographic algorithms that could allow an attacker to decrypt highly sensitive information. IBM X-Force ID: 152925.
The bug was discovered 04/10/2019. The weakness was shared 04/15/2019 (Website). The advisory is shared for download at exchange.xforce.ibmcloud.com. This vulnerability is traded as CVE-2018-1925 since 12/13/2017. The exploitability is told to be difficult. It is possible to launch the attack remotely. The exploitation doesn't require any form of authentication. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 08/29/2023). It is expected to see the exploit prices for this product increasing in the near future.The MITRE ATT&CK project declares the attack technique as T1600.
The vulnerability was handled as a non-public zero-day exploit for at least 5 days. During that time the estimated underground price was around $5k-$25k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Once again VulDB remains the best source for vulnerability data.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.8VulDB Meta Temp Score: 5.8
VulDB Base Score: 5.6
VulDB Temp Score: 5.6
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 5.9
NVD Vector: 🔍
CNA Base Score: 5.9
CNA Vector (IBM Corporation): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Inadequate encryptionCWE: CWE-326 / CWE-310
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
12/13/2017 🔍04/10/2019 🔍
04/15/2019 🔍
04/16/2019 🔍
08/29/2023 🔍
Sources
Vendor: ibm.comAdvisory: exchange.xforce.ibmcloud.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2018-1925 (🔍)
GCVE (CVE): GCVE-0-2018-1925
GCVE (VulDB): GCVE-100-133404
X-Force: 152925
Entry
Created: 04/16/2019 10:23Updated: 08/29/2023 09:36
Changes: 04/16/2019 10:23 (57), 05/29/2020 17:38 (1), 08/29/2023 09:32 (3), 08/29/2023 09:36 (12)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.